Study of Nab-paclitaxel (Abraxane®) Treatment in Patients With Metastatic Breast Cancer in Routine Clinical Practice
Status: TERMINATED
Study type: OBSERVATIONAL
Conditions: Breast Neoplasms
Sponsor: Celgene Corporation